Quick Answer
Adaptimmune Therapeutics PLC reported Shares Outstanding of 1.54 billion shares for fiscal year 2024.
Adaptimmune Therapeutics PLC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 1.54B | +12.7% |
| 2023 | 1.36B | +38.1% |
| 2022 | 987.11M | +6.3% |
| 2021 | 928.55M | -0.0% |
| 2020 | 928.75M | +47.2% |
| 2019 | 631.00M | +0.6% |
| 2018 | 627.45M | +11.6% |
| 2017 | 562.12M | +32.3% |
| 2016 | 424.78M | +0.0% |
| 2015 | 424.71M | +0.0% |
| 2015 | 424.71M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | 1.59B | +3.7% | +2.8% |
| March 31, 2025 | 1.55B | +0.9% | +0.7% |
| December 31, 2024 | 1.54B | +12.7% | +0.1% |
| September 30, 2024 | 1.53B | +12.7% | +0.0% |
| June 30, 2024 | 1.53B | +13.5% | +0.1% |
| March 31, 2024 | 1.53B | +54.3% | +12.5% |
| December 31, 2023 | 1.36B | +38.1% | +0.1% |
| September 30, 2023 | 1.36B | +38.6% | +0.7% |
- Adaptimmune Therapeutics PLC showed an increase of +12.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2024 period, Adaptimmune Therapeutics PLC’s shares outstanding has grown by 261.6% (from 424.71 million shares to 1.54 billion shares).
- The most recent figure is from Adaptimmune Therapeutics PLC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: